Overview
Benzbromarone has been used in trials studying the basic science and treatment of Heart Failure, Hyperuricemia, Chronic Kidney Disease, Abnormal Renal Function, and Gout and Asymptomatic Hyperuricemia.
Indication
本品为强有力的促尿酸排泄药，适用于反复发作的痛风性关节炎伴高尿酸血症及痛风石。
Associated Conditions
- Gout
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2022/08/17 | Phase 2 | Completed | |||
2018/05/23 | Phase 4 | UNKNOWN | National Defense Medical Center, Taiwan | ||
2017/06/14 | Phase 2 | Completed | |||
2017/04/04 | Phase 3 | Completed | |||
2016/10/25 | Not Applicable | UNKNOWN | Shanghai 10th People's Hospital | ||
2016/06/03 | Phase 2 | Completed | Medical University of Graz | ||
2015/01/14 | Not Applicable | Completed | Shanghai 10th People's Hospital | ||
2014/12/17 | Phase 1 | Completed | |||
2007/01/15 | Phase 4 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| NARCARICIN MITE TABLET 50 mg | SIN06371P | TABLET | 50 mg | 7/3/1991 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Benzbromarone Tablets | 国药准字H19990335 | 化学药品 | 片剂 | 7/30/2020 | |
| Benzbromarone Tablets | 国药准字H20204016 | 化学药品 | 片剂 | 6/10/2020 | |
| Benzbromarone Tablets | 国药准字HJ20171302 | 化学药品 | 片剂 | 8/18/2022 | |
| Benzbromarone Tablets | 国药准字HJ20171301 | 化学药品 | 片剂 | 8/18/2022 | |
| Benzbromarone Tablets | 国药准字H20223418 | 化学药品 | 片剂 | 6/23/2022 | |
| Benzbromarone Tablets | 国药准字H20040348 | 化学药品 | 片剂 | 6/10/2020 | |
| Benzbromarone Capsules | 国药准字H20040592 | 化学药品 | 胶囊剂 | 9/18/2024 | |
| Benzbromarone Capsules | 国药准字H20010790 | 化学药品 | 胶囊剂 | 8/17/2020 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| NARCARICIN CAP 50MG | N/A | N/A | N/A | 8/1/1994 |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.